On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated ...

The Food and Drug Administration (FDA) has approved the first generic version of Venofer ® (iron sucrose) Injection.

Amphastar Pharmaceuticals (AMPH) upgraded to Buy by Needham after FDA approval for generic iron sucrose injection, marking ...

The FSSAI has formed a committee to evaluate the addition of sugar in infant food products, following criticism of Nestle's ...

Iron sucrose injection is indicated for the treatment of iron deficiency anemia in patients with chronic kidney disease.

According to the FDA, Amphastar's iron sucrose injection meets the criteria for bioequivalence and therapeutic equivalence to ...

SOURCED from the famed “golden milk source belt” at 47° North Latitude, pure fresh milk formula AceKid is now in the ...

Viatris (VTRS) stock gains as the FDA OK its generic Iron Sucrose Injection targeting Venofer marketed by Daiichi Sankyo (DSKYF) (DSNKY) and Vifor. Read more here.

Generic versions of CSL’s iron replacement therapy Venofer have arrived in the U.S. after a yearslong wait. | Generic ...

Venofer was approved in the U.S. in 2000. It was developed by Vifor Pharma, which is now part of CSL Ltd. American Regent, a unit of Daiichi Sankyo, manufactures and sells it in the U.S. under a ...

Breaks down the chemical properties of cotton versus sucrose, exploring why appearance can be deceiving in edible and ...

High intake of the artificial sweetener sucralose may reduce the efficacy of ICIs in patients with cancer, data suggest.